We are looking for interested investors for the company Meta-IQ. Or companies that are interested in co-development of projects with Meta-IQ.
The first products in Meta-IQ are M-IQ 001 which is targetting Alzheimer, and M-IQ 002 for the treatment of depresion. Meta IQ has other projects for the treatment of Multiple Sclerosis and Brain tumors as you can see in the Meta-IQ presentation and Brochure.
M-IQ 001 and M-IQ 002 are small molecules that intervene in the energy metabolism. For these molecules a CMC process has been established that will be able to provide drugs for the market. The pharmacology toxicology has also been performed. It is expected that with an investment a clinical trial can be initiated Q2 2010 in Alzheimer and/or depression. For more information you can read the Meta-IQ investment brochure by pressing the link below.
Management
